Fill Patterns of Glucose-Lowering Drugs with Cardiovascular and Kidney Benefits in the Rural and Urban United States, 2012–2021
Link
Description
Analyzes fill rates for GLP1RA and SGLT2i glucose-lowering drugs among people with type 2 diabetes by level of rurality and other demographics, utilizing 2012-2021 OptumLabs Data Warehouse claims data. Discusses how geographic differences in prescribing may influence cardiovascular and kidney disease outcomes among people with type 2 diabetes.
Author(s)
Kyle Steiger, Kavya Sindhu Swarna, Jeph Herrin, Rozalina G. McCoy
Citation
Journal of General Internal Medicine, 41, 126-133
Date
08/2025
Tagged as
Cardiovascular disease
· Diabetes
· Health conditions
· Pharmacy and prescription drugs
· Rural-urban differences
· Statistics and data
